Vident Advisory’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,125
| Closed | -$53.6K | – | 1694 |
|
|
2025
Q1 | $53.6K | Sell |
10,125
-1,647
| -14% | -$8.71K | ﹤0.01% | 1532 |
|
|
2024
Q4 | $79.6K | Buy |
+11,772
| New | +$79.6K | ﹤0.01% | 1412 |
|
|
2024
Q3 | – | Sell |
-18,363
| Closed | -$138K | – | 1531 |
|
|
2024
Q2 | $138K | Sell |
18,363
-398
| -2% | -$2.99K | ﹤0.01% | 1336 |
|
|
2024
Q1 | $187K | Sell |
18,761
-1,007
| -5% | -$10K | ﹤0.01% | 1228 |
|
|
2023
Q4 | $195K | Sell |
19,768
-7,381
| -27% | -$72.8K | ﹤0.01% | 1224 |
|
|
2023
Q3 | $208K | Buy |
+27,149
| New | +$208K | 0.01% | 1094 |
|